1,524 results on '"Rogler, G."'
Search Results
2. P225 Mucosal transcriptomic profiles associated with clinical response in patients with Ulcerative Colitis receiving filgotinib
3. P561 Reasons for low use of topical 5-ASA formulations in patients treated for ulcerative colitis: comparison of doctors and patients perspectives
4. P678 Long-term efficacy, safety and health-related quality of life in patients who achieved comprehensive disease control with filgotinib in SELECTION: analysis of ~3 years in SELECTIONLTE
5. Ein globaler Consensus zu Definitionen, Diagnostik und Behandlungsmanagement des fibrostenotischen Morbus Crohn des terminalen Ileums
6. OP35 Efficacy and safety outcomes up to ~4 years of treatment with filgotinib 200 mg among patients with Ulcerative Colitis: Results from the SELECTIONLTE study
7. P270 A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn’s disease
8. Eine neue Dynamik in den Therapiestrategien der chronisch-entzündlichen Darmerkrankungen
9. Severity of local inflammation does not impact development of fibrosis in mouse models of intestinal fibrosis
10. Segundo consenso europeo basado en evidencia sobre el diagnóstico y tratamiento de la colitis ulcerosa crónica idiopática. Parte 3: situaciones especiales (versión española)
11. Interactions between sleep and gut bacteria in healthy developing infants
12. Clostridium-difficile-Infektion
13. Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (Nature Communications, (2020), 11, 1, (995), 10.1038/s41467-019-14275-y)
14. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus
15. Topical therapy is underused in patients with ulcerative colitis
16. DOP079 Heat-shock protein GP96 is essential for self-renewal of the intestinal epithelial barrier
17. DOP044 Efficacy, safety and long-term outcome of endoscopic dilation therapy for Crohn’s disease strictures of the upper gastrointestinal tract: an international multicentre cohort study including 99 patients with 129 dilation procedures
18. DOP025 Tofacitinib for the treatment of ulcerative colitis: analysis of malignancy rates from the OCTAVE clinical programme
19. DOP021 Immunosuppressive and anti-TNF treatment is associated with a lower risk of migration from B1-to-B3-stage in Crohn’s disease: 10-year follow-up data from the Swiss IBD cohort study
20. OP037 Risk of cancer in inflammatory bowel disease patients is associated with age and recent use of immunomodulators, while biologics and aminosalicylates are protective factors: a cross-sectional and follow-up analysis of the Swiss IBD cohort study
21. OP030 Loss of PTPN2 in dendritic cells promotes T-cell activation and expression of co-stimulatory molecules
22. OP020 The clinical determinants affect gut microbial profile of inflammatory bowel disease patients
23. OP027 SUCNR1 receptor mediates intestinal fibrosis
24. Genetic polymorphisms associated with smoking behaviour predict the risk of surgery in patients with Crohnʼs disease
25. Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines
26. Was bringen neue Zytokine und Antizytokine bei chronisch entzündlichen Darmerkrankungen?
27. From Alpha Diversity to Zzz:Interactions among sleep, the brain, and gut microbiota in the first year of life
28. P768 Co-housing DSS treated mice with healthy mice results in faster recovery and normalization of the intestinal microbiota
29. P711 Vegetarian or gluten-free diet in patients with IBD – associated with lower psychological well-being and quality of life but no indication of beneficial effects on course of disease
30. P712 Risk factors for the development of fistulae and stenoses in Crohnʼs disease patients in the Swiss IBD cohort
31. P566 Frequency and type of drug-related side effects necessitating drug cessation in the Swiss inflammatory bowel disease cohort
32. P569 Sequential rescue treatments in steroid refractory ulcerative colitis: two-year follow-up
33. P522 A multicenter study to validate Magnetic Resonance Enterography against histological assessments of stenotic disease in patients with Crohnʼs disease
34. P304 Zinc levels, interplay with ATG16L1 and disease outcome in Crohnʼs disease patients in the Swiss IBD cohort study
35. P298 Comparison between clinical and patient-reported symptoms among Crohnʼs disease and ulcerative colitis patients
36. P064 EBI2 and oxysterols in the development of intestinal lymphoid structures and colitis
37. P130 Ingestion of 100ml and 300ml blood mimicking upper gi bleeding leads to significant calprotectin elevation in healthy volunteers – results from the “Vampire study”
38. P102 Hypoxia reduces inflammation through the downregulation of NLRP3/mTOR signaling and the activation of autophagy
39. P072 The role of the rs8005161 polymorphism on pH-sensing G protein-coupled receptor GPR65 (TDAG8) signalling in intestinal inflammation
40. P052 The role of TDAG8 in intestinal inflammation
41. P017 OGR1 (GPR68) expression is increased in intestinal inflammation and correlates with disease activity in patients with IBD
42. P013 Decreased fibrogenesis in CH25H knockout mice in a mouse model of intestinal fibrosis
43. DOP089 PTPN2 controls intestinal inflammation and promotes colitis-associated tumour formation via control of inflammasome activation and IL-1alpha release
44. DOP055 Results of the Fifth Scientific Workshop of the ECCO (II): clinical aspects of perianal fistulising Crohnʼs disease – the unmet needs
45. DOP059 New human gut xenograft mouse model for intestinal fistulas
46. DOP056 Pathophysiology of perianal fistulising disease
47. OP034 Efficacy and safety of abrilumab in subjects with moderate to severe ulcerative colitis: results of a phase 2b, randomised, double-blind, multiple-dose, placebo-controlled study
48. OP004 Resetting of the mucosal T cell repertoire after hematopoietic stem cell transplantation in refractory Crohnʼs disease
49. Differenzialdiagnose der entzündlichen Enddarmerkrankungen
50. From Alpha Diversity to Zzz: Interactions among sleep, the brain, and gut microbiota in the first year of life
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.